{"groups":[{"description":"Carboplatin AUC 6 IV on day 1 plus Paclitaxel 175 mg/m2 IV on day 1 x 8 cycles","id":"FG000","title":"Carbo/Taxol"},{"description":"Carboplatin AUC 5 IV on day 1 plus Paclitaxel 175 mg/m2 IV on day 1 x 8 cycles plus Gemcitabine 800 mg/m2/dIV on days 1 and 8 x 8 cycles","id":"FG001","title":"Carbo/Taxol/Gemcitabine"},{"description":"Carboplatin AUC 5 IV on day 1 plus Paclitaxel 175 mg/m2 IV on day 1 x 8 cycles plus Doxil 30 mg/m2 IV every other cycle on day 1 x 8 cycles","id":"FG002","title":"Carbo/Taxol/Doxil"},{"description":"Topotecan 1.25 mg/m2/dIV days 1-3 plus Carboplatin AUC 5 IV on day 3 plus x 4 cycles followed by Carboplatin AUC 6 IV on day 1 plus Paclitaxel 175 mg/m2 IV on day 1 x 4 cycles","id":"FG003","title":"Carbo/Topotecan - Carbo/Taxol"},{"description":"Gemcitabine 1000 mg/m2/dIV on days 1 and 8 plus Carboplatin AUC 6 IV on day 8 plus x 4 cycles followed by Carboplatin AUC 6 IV on day 1 plus Paclitaxel 175 mg/m2 IV on day 1 x 4 cycles","id":"FG004","title":"Carbo/Gemcitabine - Carbo/Taxol"}],"periods":[{"milestones":[{"achievements":[{"groupId":"FG000","numSubjects":"864"},{"groupId":"FG001","numSubjects":"864"},{"groupId":"FG002","numSubjects":"862"},{"groupId":"FG003","numSubjects":"861"},{"groupId":"FG004","numSubjects":"861"}],"type":"STARTED"},{"achievements":[{"groupId":"FG000","numSubjects":"862"},{"groupId":"FG001","numSubjects":"860"},{"groupId":"FG002","numSubjects":"854"},{"groupId":"FG003","numSubjects":"846"},{"groupId":"FG004","numSubjects":"851"}],"type":"Initiated Treatment"},{"achievements":[{"groupId":"FG000","numSubjects":"864"},{"groupId":"FG001","numSubjects":"864"},{"groupId":"FG002","numSubjects":"862"},{"groupId":"FG003","numSubjects":"861"},{"groupId":"FG004","numSubjects":"861"}],"type":"COMPLETED"},{"achievements":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"0"},{"groupId":"FG003","numSubjects":"0"},{"groupId":"FG004","numSubjects":"0"}],"type":"NOT COMPLETED"}],"title":"Overall Study"}],"preAssignmentDetails":"This study involved patients enrolled from two cooperative groups with the plan to combine data. 3882 patients were enrolled from one cooperative group and 430 from the other. This report includes those patients from both groups.","recruitmentDetails":"Received began 1/29/2001 and ended 1/28/2003. This was an interventional trial involving patients enrolled from the United States (US), Canada, United Kingdom (UK), Italy, Australia, and New Zealand."}